| ivabradine / Generic mfg. |
ACTRN12616001634460p: Ivabradine in the Prevention of Cardiac Injury in patients undergoing major Orthopaedic surgery. |
|
|
| Not yet recruiting | 2 | 200 | | | Department of Cardiology, Northern Hospital, Department of Cardiology, Northern Hospital | Cardiac injury; Mortality; Orthopaedic Surgery | | | | |
ACTRN12616001634460: Ivabradine in the Prevention of Cardiac Injury in patients undergoing major Orthopaedic surgery. |
|
|
| Not yet recruiting | 2 | 200 | | | Department of Cardiology, Northern Hospital, Department of Cardiology, Northern Hospital | Cardiac injury, Mortality, Orthopaedic Surgery | | | | |
ACTRN12616000940471: A Phase II Feasibility study to determine the efficacy and dose-response of a single enteral dose of Ivabradine to reduce participant heart rate in patients admitted to the intensive care unit with sepsis and sinus tachycardia |
|
|
| Recruiting | 2 | 20 | | | A/Prof Andrew Udy,, The Alfred Research Trust: Alfred Small Projects Grants | Sepsis, tachycardia | | | | |
ACTRN12618002056279: Effect of heart rate reduction on kidney, eye and skin complications of type 2 diabetes mellitus study
|
|
|
| Recruiting | 2 | 50 | | | Royal Perth Hospital, Heart Foundation | Type 2 diabetes mellitus | | | | |
2006-005886-21: Evaluation des effets de l’ivabradine 5 mg et 7.5 mg en 2 prises par jour par voie orale chez des patients insuffisants cardiaques avec une hypertension artérielle insuffisamment équilibrée par Perindopril 4 mg/j par voie orale.Etude ouverte, multicentrique |
|
|
| Ongoing | 2 | 30 | Europe | S16257, S09490, S16257, S09490, PROCORALAN, COVERSYL, PROCORALAN, COVERSYL | Institut de Recherches Internationales Servier | Insuffisance cardiaque | | | | |
2012-000215-89: Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial function |
|
|
| | 2 | 200 | Europe | S16257, S16257, Procoralan, Procoralan | Institut de Recherches Internationales Servier, ADIR | Cardiovascular disease | | 04/14 | | |
2019-003902-29: Early Administration of Ivabradine in Children with Heart Failure. “Somministrazione precoce di ivabradina nei bambini ospedalizzati per scompenso cardiaco-EArly adminiStration of Ivabradine in CHILDren with heart failure EASI-Child- studio pilota” |
|
|
| Not yet recruiting | 2 | 9 | Europe | Procoralan, Corlanor, [na], [NA], Tablet, Oral solution, Procoralan, Corlanor | IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA, Ministero della Salute | Acute hearth failure in dilated cardiomyopathy. Insufficienza cardiaca acuta nella cardiomiopatia dilatativa, dilated cardiomyopathy. cardiomiopatia dilatativa, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Enrolling by invitation | 2 | 9 | Europe | Ivabradine 5Mg Tab | Bambino Gesù Hospital and Research Institute, Ministero della Salute, Italy | Acute Heart Failure, Dilated Cardiomyopathy | 01/21 | 05/21 | | |
NCT04580342: Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery |
|
|
| Recruiting | 2 | 60 | RoW | oral Ivabradine, oral Propranolol | Ahmed talaat ahmed aly | Hypotension | 01/21 | 01/21 | | |
2021-006994-48: Empower the Heart of Patients with Terminal Cancer using Cardiac Medicines Trial |
|
|
| Not yet recruiting | 2 | 72 | Europe | Entresto, Solution for injection/infusion, Film-coated tablet, Ferinject®50 mg Eisen/ml, Jardiance® 10 mg, Procoralan® 5 mg, Procoralan® 7.5 mg, Entresto® 24 mg/26 mg, Entresto® 49 mg/51 mg, Entresto® 97 mg/103 mg | Universitätsklinikum Essen, Universitätsklinikum Essen | Patients with terminal cancer in palliative care, Patients with terminal cancer in palliative care, Diseases [C] - Cancer [C04] | | | | |
| Recruiting | 2 | 180 | US | Ivabradine, Ivabradine Placebo, Coordinated Care, Usual Care | Kanecia Obie Zimmerman | Long COVID, Long Covid19, Long Covid-19 | 12/25 | 03/26 | | |
| Enrolling by invitation | 2 | 380 | US | IVIG + Coordinated Care, IVIG Placebo + Coordinated Care, Ivabradine + Coordinated Care, Ivabradine Placebo + Coordinated Care, IVIG + Usual Care, IVIG Placebo + Usual Care, Ivabradine + Usual Care, Ivabradine Placebo + Usual Care | Kanecia Obie Zimmerman | Long COVID, Long Covid19, Long Covid-19 | 12/25 | 03/26 | | |
NCT04186286: Crossover Study of Propranolol vs Ivabradine in POTS |
|
|
| Recruiting | 2 | 20 | Canada | Ivabradine 4-week course, Lancora, Propranolol 4-week course, Inderal, Placebo 4-week course | University of Calgary, Dysautonomia International | Postural Tachycardia Syndrome | 12/25 | 12/26 | | |
